E-LIB Suche - Ergebnisse für: Kobayashi, Kazufumi

1

Clinical risk factors for portal hypertension-related compl..:

Fujiwara, Kisako ; Kondo, Takayuki ; Fujimoto, Kentaro...
Journal of Gastroenterology. 59 (2024) 6 - p. 515-525 , 2024

Link: https://doi.org/10.1007/..

2

Ramucirumab for advanced hepatocellular carcinoma in the cu..:

Kobayashi, Kazufumi ; Ogasawara, Sadahisa ; Itobayashi, Ei...
Investigational New Drugs. , 2024

Link: https://doi.org/10.1007/..

3

SAT-335 Pathological dynamics and clinical implications of ..:

Izai, Ryo ; Ogasawara, Sadahisa ; Akatsuka, Teppei...
Journal of Hepatology. 80 (2024) - p. S123-S124 , 2024

Link: https://doi.org/10.1016/..

4

SAT-095 Trial of the establishment of shear wave elastograp..:

Unozawa, Hidemi ; Kondo, Takayuki ; Fujimoto, Kentaro...
Journal of Hepatology. 80 (2024) - p. S247 , 2024

Link: https://doi.org/10.1016/..

5

Cytokine release syndrome following durvalumab and tremelim..:

Ozaki, Tomomi ; Yumita, Sae ; Ogasawara, Sadahisa...
Hepatology Research. , 2024

Link: https://doi.org/10.1111/..

6

Assessment of Macrovascular Invasion in Advanced Hepatocell..:

Inoue, Masanori ; Ogasawara, Sadahisa ; Kobayashi, Kazufumi...
Liver Cancer. , 2024

Link: https://doi.org/10.1159/..

7

Impact of skeletal muscle volume on patients with BCLC stag..:

Saeki, Issei ; Yamasaki, Takahiro ; Yamauchi, Yurika...
Cancer Medicine. 12 (2023) 9 - p. 10625-10635 , 2023

Link: https://doi.org/10.1002/..

8

Hyperprogressive disease during atezolizumab plus bevacizum..:

Yumita, Sae ; Ogasawara, Sadahisa ; Nakagawa, Miyuki...
BMC Gastroenterology. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

9

Miglustat, a glucosylceramide synthase inhibitor, mitigates..:

Iwanaga, Terunao ; Chiba, Tetsuhiro ; Nakamura, Masato...
Biochemical and Biophysical Research Communications. 642 (2023) - p. 192-200 , 2023

Link: https://doi.org/10.1016/..

10

Cabozantinib for Advanced Hepatocellular Carcinoma in the L..:

Kanzaki, Hiroaki ; Ogasawara, Sadahisa ; Okubo, Tomomi...
Drugs - Real World Outcomes. 10 (2023) 4 - p. 513-520 , 2023

Link: https://doi.org/10.1007/..

11

Estimation of the effect of atezolizumab plus bevacizumab o..:

Kondo, Takayuki ; Fujiwara, Kisako ; Nakagawa, Miyuki...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

12

Use of ramucirumab for various treatment lines in real-worl..:

Kanogawa, Naoya ; Ogasawara, Sadahisa ; Maruta, Susumu...
BMC Gastroenterology. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

13

Potential of circulating receptor-interacting protein kinas..:

Kondo, Takayuki ; Fujimoto, Kentaro ; Fujiwara, Kisako...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

Effect of Atezolizumab plus Bevacizumab in Patients with He..:

Ogawa, Keita ; Kanzaki, Hiroaki ; Chiba, Tetsuhiro...
Journal of Cancer. 13 (2022) 8 - p. 2656-2661 , 2022

Link: https://doi.org/10.7150/..

15

Real‐world outcomes of molecular targeted agents for patien..:

Sato, Rui ; Moriguchi, Michihisa ; Iwai, Kenji...
Hepatology Research. 52 (2022) 10 - p. 859-871 , 2022

Link: https://doi.org/10.1111/..